<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04480775</url>
  </required_header>
  <id_info>
    <org_study_id>(MS.20.01.999-2020/01/10)</org_study_id>
    <nct_id>NCT04480775</nct_id>
  </id_info>
  <brief_title>Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block</brief_title>
  <acronym>triamcinolone</acronym>
  <official_title>Triamcinolone Versus Methylprednisolone in Ultrasound Guided Transversus Abdominis Plane Block in Major Open Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ghada fouad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the current Study we will compare between triamcinolone and methylprednisolone as an&#xD;
      additive to bupivacaine drug in ultrasound guided TAP block in major open abdominal surgery .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative pain is one of the main causes of respiratory function derangement after&#xD;
      abdominal surgery .Transversus abdominis plane (TAP) block is widely used in abdominal&#xD;
      surgery for postoperative analgesia The transversus abdominis plane (TAP) block is&#xD;
      aperipheral nerve block that involves the injection of alocal anesthetic (LA) in the plane&#xD;
      between the internaloblique and transversus abdominis muscle layers, with the aim of&#xD;
      anesthetizing the intercostal nerves supplyingthe abdominal wall (from T6 to L1) By blocking&#xD;
      intercostal nerves T6 to L1, TAPblock efficiently blocks somatic pain after abdominalwall&#xD;
      surgery&#xD;
&#xD;
      . It providesadequate postoperative pain relief following various abdominal surgeries TAP&#xD;
      block can reduce pain scores, opioid consumption, and the incidence of opioid-related&#xD;
      complications after abdominal surgery.&#xD;
&#xD;
      The duration of the TAP block is limited to theeffect of the administered LAs. Various&#xD;
      adjuvantmedications have been added to the LA to prolong theduration of TAP block and magnify&#xD;
      its effects .&#xD;
&#xD;
      Perineural injection of steroids is reported to influence postoperative analgesia.&#xD;
&#xD;
      As a synthetic glucocorticoid, triamcinolone acetonide binds to and activates the&#xD;
      glucocorticoid receptor to produce anti-inflammatory responses,such as down-regulating&#xD;
      pro-inflammatory cytokine expression , preventing prostaglandin and leukotriene synthesis and&#xD;
      release of arachidonic acid, and activating anti-inflammatory transcription factors such as&#xD;
      lipocortins&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 15, 2020</start_date>
  <completion_date type="Actual">December 15, 2020</completion_date>
  <primary_completion_date type="Actual">December 15, 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patient will be evaluated pre operative and full lab will be done In the Pre Anaesthesia Room ,a 20 gauge venous catheter will be inserted in the upper limb , and monitoring included heart rate, electrocardiogram, noninvasiveblood pressure, and peripheral oxygen saturation.Oxygen at the rate of 6 L/min will beadministered through oxygen mask to all patients.&#xD;
The anesthesiologist who performed the block will be blinded to drug solution and not involved in data collection, another anesthesiologist will prepare drug solution and other anesthesiologist collect the data.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>double blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>analgesic effect of Triamcinolone and Methylprednisolone In Ultrasound Guided Transversus Abdominis Plane Block ( Tap Block ).</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>visual analogue scale for assessement of pain from 0 to 10 is used where 0 is no pain and 10 is maximum pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>occurance of complication</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>nausea vomiting hemodynamic changes</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Major Abdominal Surgery</condition>
  <arm_group>
    <arm_group_label>bupivacaine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>28 Patients will receive 18 ml of bupivacaine 0.5 % plus 1ml 0.9% saline in TAP block divided equally on both sides</description>
  </arm_group>
  <arm_group>
    <arm_group_label>triamicinolone group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>28 Patient will receive 18 ml of bupivacaine 0.5 % plus (20 mg of triamcinolone in 1ml 0.9% saline divided equally on both sides in TAP block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>methylprednisolone group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>28 Patient will receive 18 ml of bupivacaine 0.5 % plus (40 mg of methylprednisolone in 1ml 0.9% saline ) on both sides in TAP block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone</intervention_name>
    <description>transversus abdominis plane block with bupivacain and triamicinolone</description>
    <arm_group_label>triamicinolone group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone</intervention_name>
    <description>transversus abdominis plane block with bupivacaine and methylprednisolone</description>
    <arm_group_label>methylprednisolone group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <description>transversus abdominis plane block with bupivacaine alone</description>
    <arm_group_label>bupivacaine group</arm_group_label>
    <arm_group_label>methylprednisolone group</arm_group_label>
    <arm_group_label>triamicinolone group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled for major open abdominal surgery&#xD;
&#xD;
          -  American Society Anesthesiologists (ASA) physical status I to II&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal.&#xD;
&#xD;
          -  Morbidly obese patients.&#xD;
&#xD;
          -  Patients with uncontrolled diabetes.&#xD;
&#xD;
          -  Severe or uncontrolled renal, hepatic or endocrinal diseases.&#xD;
&#xD;
          -  Pregnancy, post-partum or lactating females&#xD;
&#xD;
          -  Allergy to one of the agents used.&#xD;
&#xD;
          -  Recent (less than six months) use of glucocorticoids for at least two weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>marwa M elegemazy, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ghada f amer, M.D</last_name>
    <role>Study Director</role>
    <affiliation>associate professor of anesthesia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eiad a ramzy, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>associate professor of anesthesia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>abdelaziz a motaweaa, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>professor of anesthesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura University</name>
      <address>
        <city>Mansoura</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>July 13, 2020</study_first_submitted>
  <study_first_submitted_qc>July 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2020</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>ghada fouad</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>triamicinolone</keyword>
  <keyword>methylprednisolone</keyword>
  <keyword>transversus abdominisus plane block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

